231 related articles for article (PubMed ID: 34130108)
1. Glioblastoma-specific anticancer activity of newly synthetized 3,5-disubstituted isoxazole and 1,4-disubstituted triazole-linked tyrosol conjugates.
Aissa I; Abdelkafi-Koubaa Z; Chouaïb K; Jalouli M; Assel A; Romdhane A; Harrath AH; Marrakchi N; Ben Jannet H
Bioorg Chem; 2021 Sep; 114():105071. PubMed ID: 34130108
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells.
da Silva VD; de Faria BM; Colombo E; Ascari L; Freitas GPA; Flores LS; Cordeiro Y; Romão L; Buarque CD
Bioorg Chem; 2019 Mar; 83():87-97. PubMed ID: 30343205
[TBL] [Abstract][Full Text] [Related]
3. Tyrosol Derivatives, Bearing 3,5-Disubstituted Isoxazole and 1,4-Disubstituted Triazole, as Potential Antileukemia Agents by Promoting Apoptosis.
Abdelkafi-Koubaa Z; Aissa I; Ben Jannet H; Srairi-Abid N; Marrakchi N; Menif S
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014333
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents.
Naresh Kumar R; Jitender Dev G; Ravikumar N; Krishna Swaroop D; Debanjan B; Bharath G; Narsaiah B; Nishant Jain S; Gangagni Rao A
Bioorg Med Chem Lett; 2016 Jun; 26(12):2927-2930. PubMed ID: 27130357
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 1,2,3-triazole/isoxazole functionalized 2H-Chromene derivatives and their cytotoxic activity.
Ratnakar Reddy K; Sambasiva Rao P; Jitender Dev G; Poornachandra Y; Ganesh Kumar C; Shanthan Rao P; Narsaiah B
Bioorg Med Chem Lett; 2014 Apr; 24(7):1661-3. PubMed ID: 24641975
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of some novel methyl β-orsellinate based 3, 5-disubstituted isoxazoles and their anti-proliferative activity: Identification of potent leads active against MCF-7 breast cancer cell.
Reddy ST; Mendonza JJ; Makani VKK; Bhadra MP; Uppuluri VM
Bioorg Chem; 2020 Dec; 105():104374. PubMed ID: 33130349
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of novel levoglucosenone derivatives as promising anticancer agents.
Tsai YH; Borini Etichetti CM; Cicetti S; Girardini JE; Spanevello RA; Suárez AG; Sarotti AM
Bioorg Med Chem Lett; 2020 Jul; 30(14):127247. PubMed ID: 32527547
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 3-hydroxymethyl-5-(1H-1,2,3-triazol) isoxazolidines.
Romeo R; Giofrè SV; Carnovale C; Campisi A; Parenti R; Bandini L; Chiacchio MA
Bioorg Med Chem; 2013 Dec; 21(24):7929-37. PubMed ID: 24436994
[TBL] [Abstract][Full Text] [Related]
9. Microwave-assisted synthesis, anti-inflammatory and anti-proliferative activities of new maslinic acid derivatives bearing 1,5- and 1,4-disubstituted triazoles.
Chouaïb K; Delemasure S; Dutartre P; Jannet HB
J Enzyme Inhib Med Chem; 2016; 31(sup2):130-147. PubMed ID: 27435116
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents.
Shakeel-u-Rehman ; Masood-ur-Rahman ; Tripathi VK; Singh J; Ara T; Koul S; Farooq S; Kaul A
Bioorg Med Chem Lett; 2014 Sep; 24(17):4243-6. PubMed ID: 25088398
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological studies of new piperidino-1,2,3-triazole hybrids with 3-aryl isoxazole side chains.
Murthy AVR; Narendar V; Sampath Kumar N; Aparna P; Bhavani AKD; Solhi H; Le Guevel R; Roul J; Gautier F; Juin P; Reddy CR; Mosset P; Levoin N; Grée R
Bioorg Med Chem Lett; 2021 Nov; 52():128390. PubMed ID: 34601029
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents.
Kumbhare RM; Kosurkar UB; Janaki Ramaiah M; Dadmal TL; Pushpavalli SN; Pal-Bhadra M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5424-7. PubMed ID: 22858144
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel flavone/triazole/benzimidazole hybrids and flavone/isoxazole-annulated heterocycles as antiproliferative and antimycobacterial agents.
Rao YJ; Sowjanya T; Thirupathi G; Murthy NYS; Kotapalli SS
Mol Divers; 2018 Nov; 22(4):803-814. PubMed ID: 29869169
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
Grytsai O; Valiashko O; Penco-Campillo M; Dufies M; Hagege A; Demange L; Martial S; Pagès G; Ronco C; Benhida R
Bioorg Chem; 2020 Nov; 104():104271. PubMed ID: 32992279
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies.
Oubella A; El Mansouri AE; Fawzi M; Bimoussa A; Laamari Y; Auhmani A; Morjani H; Robert A; Riahi A; Youssef Ait Itto M
Bioorg Chem; 2021 Oct; 115():105184. PubMed ID: 34333421
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors.
Im D; Jung K; Yang S; Aman W; Hah JM
Eur J Med Chem; 2015 Sep; 102():600-10. PubMed ID: 26318067
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiproliferative activity of 8-hydroxyquinoline derivatives containing a 1,2,3-triazole moiety.
Freitas LB; Borgati TF; de Freitas RP; Ruiz AL; Marchetti GM; de Carvalho JE; da Cunha EF; Ramalho TC; Alves RB
Eur J Med Chem; 2014 Sep; 84():595-604. PubMed ID: 25062010
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
19. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses.
Rezki N; Almehmadi MA; Ihmaid S; Shehata AM; Omar AM; Ahmed HEA; Aouad MR
Bioorg Chem; 2020 Oct; 103():104133. PubMed ID: 32745759
[TBL] [Abstract][Full Text] [Related]
20. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
Rono CK; Darkwa J; Meyer D; Makhubela BCE
Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
